IRadimed - IRMD Stock Forecast, Price & News

0 analysts have issued 12 month target prices for IRadimed's stock. Their IRMD share price forecasts range from $48.00 to $48.00. On average, they anticipate the company's share price to reach $48.00 in the next twelve months. This suggests a possible upside of 26.7% from the stock's current price.
View analysts price targets for IRMD or view top-rated stocks among Wall Street analysts.

IRadimed's stock was trading at $28.29 on January 1st, 2023. Since then, IRMD stock has increased by 33.9% and is now trading at $37.88.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023.
View our IRMD earnings forecast.

IRadimed Co. (NASDAQ:IRMD) announced its earnings results on Thursday, February, 2nd. The medical equipment provider reported $0.29 earnings per share for the quarter, hitting the consensus estimate of $0.29. The medical equipment provider earned $14.86 million during the quarter, compared to analysts' expectations of $14.93 million. IRadimed had a trailing twelve-month return on equity of 18.81% and a net margin of 23.99%.

IRadimed announced a dividend on Monday, February 6th. Investors of record on Monday, February 13th will be paid a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, February 10th. This is an increase from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD.

Ballast Small/Mid Cap ETF holds 16,660 shares of IRMD stock, representing 0.91% of its portfolio.

IRadimed updated its fourth quarter 2022 earnings guidance on Wednesday, January, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.90 million-$14.90 million, compared to the consensus revenue estimate of $14.63 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

IRadimed's stock is owned by a variety of institutional and retail investors. Top institutional investors include Soleus Capital Management L.P. (5.93%), Renaissance Technologies LLC (4.73%), Bares Capital Management Inc. (2.16%), Russell Investments Group Ltd. (1.61%), Dimensional Fund Advisors LP (1.28%) and Geode Capital Management LLC (1.07%). Insiders that own company stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends.

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IRMD stock can currently be purchased for approximately $37.88.

IRadimed (NASDAQ:IRMD) has a market capitalization of $476.91 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.02 on an earnings per share basis.

The company employs 110 workers across the globe.

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.